Showing posts with label quality of life research journals. Show all posts
Showing posts with label quality of life research journals. Show all posts

Thursday, 4 May 2017

Current Exercise Behaviors Of Breast Cancer Patients Diagnosed With Chemotherapy-induced Peripheral Neuropathy

Chemotherapy- induced peripheral neuropathy (CIPN) is a common ailment among those taking chemotherapeutic drugs. This condition is characterized by damage to the nervous system that is a direct result of the medications associated with chemotherapy.

Little is known about the mechanisms responsible for the development of CIPN. The peripheral toxicity involved with CIPN is specific to each chemotherapy drug class, and in most cases, appears to be dose and duration dependent, however it can evolve even after a single drug application.
Chemotherapy- induced peripheral neuropathy (CIPN) is a common ailment among those taking chemotherapeutic drugs. This condition is characterized by damage to the nervous system that is a direct result of the medications associated with chemotherapy.  Little is known about the mechanisms responsible for the development of CIPN. The peripheral toxicity involved with CIPN is specific to each chemotherapy drug class, and in most cases, appears to be dose and duration dependent, however it can evolve even after a single drug application.  The chemotherapy agents Docetaxel, Paclitaxel, or Vinorelbine are used to treat breast cancer, and often result in damage to central nervous system pain pathways, resulting in neuropathic pain. PDF LINK

The chemotherapy agents Docetaxel, Paclitaxel, or Vinorelbine are used to treat breast cancer, and often result in damage to central nervous system pain pathways, resulting in neuropathic pain.

Wednesday, 28 December 2016

Quality of Life and Sexual Activity after Stereotactic Hypofractionated Radiotherapy of Prostate Cancer Patients

Quality of life (QoL) is an important factor for the cancer patients after treatment. The study aimed to investigate QoL and sexual activity in patients who had undergone stereotactic hypofractionated radiotherapy (HRT). Methods: The analysis included 82 prostate cancer patients: 40 patients treated by HRT (33.5 Gy in 5 fractions) and 42 patients treated by standard three-dimensional conformal radiation treatment 3DCRT (70-82 Gy in 35-41 fractions); and 50 healthy men without any type of cancer.

Radiotherapy of Prostate Cancer Patients
The subjects filled out the questionnaires: EORTC QLQC30 (version 3.0.) and the prostate cancer-specific EORTC QLQ-PR25. The median follow-up was 21 months for HRT patients and 28 months for 3DCRT patients. Results: The tolerance for stereotactic HRT was shown to be good. The QoL and the general health status of HRT patients were higher than of 3DCRT patients and even of healthy men. Most patients treated by HRT felt that they had lost their masculinity.

However, they were still interested in having sex; one third of them were sexually active, most reported satisfaction with their sex life. Conclusions: HRT for prostate cancer patients was an attractive treatment in relation to patients' QoL assessment in the short term analysis.


Monday, 26 September 2016

Life and Sexual Activity

Prostate cancer is the most prevalent solid tumor diagnosed in men in developed countries. The standard treatment for early stage prostate cancer is surgery (prostatectomy) or radiotherapy. To improve local control, the radiation dose should be escalated.

Hypofractionated Radiotherapy of Prostate
Three dimensional conformal radiation treatment (3DCRT) increases local control rates while decreasing toxicity rates. Recent data suggest that, to achieve high local control of prostate cancer with acceptable toxicity, hypofractionated radiotherapy (HRT) could be used. Short-duration HRT  is an attractive option compared with a 7-to-8-week course of standard radiotherapy in terms of logistics; the patient’s job, daily activities, and emotions; the availability of accelerators, and the cost of prolonged treatment.

Quality of life (QoL) has become one of the most significant issues in treatment decisions in prostate cancer. In the case of QoL measurement after radical prostatectomy, brachytherapy, or external beam radiotherapy, all types of prostate cancer treatment were shown to be associated with changes in the QoL domains related to urinary, bowel, and sexual functions.

Wednesday, 17 August 2016

Women Aged 35-55 Suffering from Breast Cancer

The span of mortality rate is significantly smaller (about 6-19 in 100.000), due to breast cancer survivals in developed regions (high incidence). As a result, breast cancer is the fifth cause of deaths in the total number of deaths (458 000 deaths), and in spite of that, it is still the leading cause of death in women from all types of cancer locations, and in countries in development (269 000 deaths, 12.7% of overall mortality) and developed regions, with an estimated number of 189 000 deaths, which is almost equal to the estimated number of deaths by lung cancer (188 000 deaths).

Women Aged 35-55 Suffering from Breast Cancer

Breast cancer was the leading cancer with women in Bosnia and Herzegovina in the year 2008, with an incidence 1100 (25.9%) with the standardized world rate ASR (W) on 100 000 inhabitants, 36.5 and mortality 399 (17%) with the standardized world rate ASR (W) 22.7.

Breast cancer as a disease effects on financial expenses and presents an economic burden for reasons that, next to the direct costs, come the costs of treatment and mortality rates. During a longer period, the expenses grow according to a similar rate for total health costs. According to the American National Institute for Health, it is estimated that breast cancer will cost 209.9 billion dollars in the year 2005, 118.4 billion of which due to mortality expenses (loss of productivity due to patient's death), 74 billion due to direct medical expenses (money spent on medical care), which used to be 17.5 billion dollars due to morbidity expenses (costs of loss of productivity due to disease.


Robert Cummins is the founder of international group of scientist and researchers (International Well-Being Group), which advocates the understanding that  life quality is a multi-dimensional construct made from: life standard, health, productivity, the ability to make close connections, security, the sense of belonging to a community, and the sense of security in the future.